Skip to content

New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.

David Y W Lee, Zhongze Ma, Lee-Yuan Liu-Chen, Yulin Wang, Yong Chen, William A Carlezon, Bruce M Cohen

Bioorganic & Medicinal Chemistry October 1, 2005 DOI: 10.1016/j.bmc.2005.05.054 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Laboratory study Peer reviewed
Topics Salvia divinorum
Key points Three new neoclerodane diterpenoids were isolated from Salvia divinorum leaves, and among all tested compounds, salvinorin A remained the most potent kappa opioid agonist, surpassing the new compounds in binding affinity.

Abstract

Bioactivity-guided fractionation of the leaves of Salvia divinorum has resulted in the isolation of three new neoclerodane diterpenoids: divinatorin D (1), divinatorin E (2), and salvinorin G (3), together with 10 known terpenoids, divinatorin C (4), hardwickiic acid (5), salvinorin-A (6), -B (7), -C (8), -D (9), -E (10), and -F (11), presqualene alcohol (12), and (E)-phytol (13). The structures of these three new compounds were characterized by spectroscopic methods. All these compounds were evaluated for their binding affinities to the human kappa opioid receptors. In comparison with divinatorin D (1), divinatorin E (2), and salvinorin G (3), salvinorin A (6) is still the most potent kappa agonist.

Comparable studies

Other experimental studies on salvia divinorum, most cited first.

Citations in the library

Cited by 31

and 26 more in the library

Cites 10

and 5 more in the library

Explore topics